{
    "id": "b6c5abdd-bc2d-4ed6-8ca2-8a94c406ed0e",
    "indications": "nebivolol tablets beta-adrenergic blocking agent indicated treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 )",
    "contraindications": "taken without food . individualize needs patient monitor up-titration . ( 2 ) • hypertension : patients start 5 mg daily . dose increased 2-week intervals 40 mg. ( 2.1 )",
    "warningsAndPrecautions": "nebivolol tablets available tablets oral containing nebivolol hydrochloride equivalent 2.5 , 5 , 10 , 20 mg nebivolol . nebivolol tablets , 2.5 mg light blue colored mottled , triangular shape , biconvex uncoated tablets debossed “ 7 ” one side plain side . bottle 30s ndc 33342-457-07 bottle 90s ndc 33342-457-10 unit- dose carton 12 x 10s ndc 33342-457-25 nebivolol tablets , 5 mg beige colored mottled , triangular shape , biconvex uncoated tablets debossed “ 8 ” one side plain side bottle 30s ndc 33342-458-07 bottle 90s ndc 33342-458-10 unit- dose carton 12 x 10s ndc 33342-458-25 nebivolol tablets , 10 mg pinkish purple colored mottled , triangular shape , biconvex uncoated tablets debossed “ 9 ” one side plain side . bottle 30s ndc 33342-459-07 bottle 90s ndc 33342-459-10 unit- dose carton 12 x 10s ndc 33342-459-25 nebivolol tablets , 20 mg light blue colored mottled , triangular shape , biconvex uncoated tablets debossed “ 10 ” one side plain side bottle 30s ndc 33342-460-07 bottle 90s ndc 33342-460-10 unit- dose carton 12 x 10s ndc 33342-460-25 store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp using child-resistant closure .",
    "adverseReactions": "nebivolol tablets contraindicated following conditions : • severe bradycardia • heart block greater first degree • patients cardiogenic shock • decompensated cardiac failure • sick sinus syndrome ( unless permanent pacemaker place ) • patients severe hepatic impairment ( child-pugh > b ) • patients hypersensitive component product .",
    "ingredients": [
        {
            "name": "NEBIVOLOL HYDROCHLORIDE",
            "code": "JGS34J7L9I"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "D&C RED NO. 27",
            "code": "2LRS185U6K"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        }
    ],
    "organization": "Macleods Pharmaceuticals Limited",
    "name": "Nebivolol",
    "effectiveTime": "20250408",
    "indications_original": "Nebivolol tablets are a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 )",
    "contraindications_original": "Can be taken with and without food. Individualize to the needs of the patient and monitor during up-titration. ( 2 ) • Hypertension: Most patients start at 5 mg once daily. Dose can be increased at 2-week intervals up to 40 mg. ( 2.1 )",
    "warningsAndPrecautions_original": "Nebivolol tablets are available as tablets for oral administration containing nebivolol hydrochloride equivalent to 2.5, 5, 10, and 20 mg of nebivolol. \n                  Nebivolol Tablets, 2.5 mg are light blue colored mottled, triangular shape, biconvex uncoated tablets debossed with “I 7” on one side and plain on the other side. Bottle of 30s         NDC 33342-457-07 Bottle of 90s         NDC 33342-457-10 Unit- Dose Carton of 12 x 10s   NDC 33342-457-25\n                  Nebivolol Tablets, 5 mg are beige colored mottled, triangular shape, biconvex uncoated tablets debossed with “I 8” on one side and plain on the other side Bottle of 30s         NDC 33342-458-07 Bottle of 90s         NDC 33342-458-10 Unit- Dose Carton of 12 x 10s   NDC 33342-458-25\n                  Nebivolol Tablets, 10 mg are pinkish purple colored mottled, triangular shape, biconvex uncoated tablets debossed with “I 9” on one side and plain on the other side. Bottle of 30s         NDC 33342-459-07 Bottle of 90s         NDC 33342-459-10 Unit- Dose Carton of 12 x 10s   NDC 33342-459-25\n                  Nebivolol Tablets, 20 mg are light blue colored mottled, triangular shape, biconvex uncoated tablets debossed with “I 10” on one side and plain on the other side Bottle of 30s         NDC 33342-460-07 Bottle of 90s         NDC 33342-460-10 Unit- Dose Carton of 12 x 10s   NDC 33342-460-25\n                  \n                     Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n                      Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions_original": "Nebivolol tablets are contraindicated in the following conditions:  • Severe bradycardia  • Heart block greater than first degree  • Patients with cardiogenic shock  • Decompensated cardiac failure  • Sick sinus syndrome (unless a permanent pacemaker is in place)  • Patients with severe hepatic impairment (Child-Pugh >B)  • Patients who are hypersensitive to any component of this product."
}